Stocks

BillionToOne BLLN

Health care sectorNasdaq

What to see in BillionToOne now

Is stock about to come to market?$13.3M

$13.3M of planned sales filed in 30 days · 0.3% of the units outstanding

Filed 09/28
Is Wall Street adding or cutting?+66

156 13F filers hold it · +66 against the quarter before · shares held +34.7%

Holdings of 06/30
Are insiders selling?−$2.1M

3 insiders, a net sale of $2.1M in 90 days

Filed 09/30

Company

Exchange
Nasdaq
Industry
Services-Medical Laboratories
Headquarters
Menlo Park, California
Fiscal year end
12/31
Next earnings
10/01, estimated
  • $13.3M of planned sales filed in 30 days · 0.3% of the units outstandingFiled 09/28
  • 3 insiders, a net sale of $2.1M in 90 daysFiled 09/30

Insider trades

Trade type
Oguzhan AtayChairman and CEO
Open-market sale10b5-1 plan09/2809/308,333 sh$120.64$1,005,293.12−100.0%
Oguzhan AtayChairman and CEO
Open-market sale10b5-1 plan09/2809/302,666 sh$120.64$321,626.24−1.7%
Bosch John Roderick tenSVP of Laboratory Operations
Open-market sale10b5-1 plan09/2409/281,416 sh$120.00$169,920−6.0%
David TsaoChief Technology Officer
Open-market sale10b5-1 plan09/2409/283,333 sh$125.00$416,625−76.9%
Bosch John Roderick tenSVP of Laboratory Operations
Open-market sale10b5-1 plan09/2109/231,416 sh$106.61$150,959.76−5.7%
All insider trades in BillionToOne

Planned sales

Oguzhan AtayMember of immediate family of any of the foregoing
BillionToOneBLLN10b5-1 plan
2,666 sh$321,626.2409/28Filed 09/28
Oguzhan AtayOfficer, Director
BillionToOneBLLN10b5-1 plan
8,333 sh$1,005,293.1209/28Filed 09/28
David TsaoOfficer, Director
BillionToOneBLLN10b5-1 plan
3,333 sh$416,62509/24Filed 09/24
BillionToOneBLLN10b5-1 plan
1,416 sh$169,92009/24Filed 09/24
BillionToOneBLLN10b5-1 plan
1,416 sh$150,959.7609/21Filed 09/21
BillionToOneBLLN10b5-1 plan
35,112 sh$3,873,965.7809/17Filed 09/17
Oguzhan AtayOfficer, Director
BillionToOneBLLN10b5-1 plan
24,999 sh$2,507,908.4409/14Filed 09/14
Oguzhan AtayMember of immediate family of any of the foregoing
BillionToOneBLLN10b5-1 plan
5,332 sh$522,53609/14Filed 09/14
David TsaoOfficer, Director
BillionToOneBLLN10b5-1 plan
1,750 sh$170,69509/09Filed 09/09
David TsaoOfficer, Director
BillionToOneBLLN10b5-1 plan
20,000 sh$2,045,32609/09Filed 09/09
All planned sales of BillionToOne

26-week trading

No member of Congress reported a trade in BillionToOne BLLN in the past 90 days. Insiders filed 0 purchases and 5 sales on the open market over the same period, a net sale of $2.1M.

Common questions

Did BillionToOne BLLN insiders buy or sell in the past 90 days?
In the past 90 days insiders filed 0 purchases and 5 sales on the open market. Sales came to $2.1M.